Supernus Wearable Device for Dosing Parkinson’s Drug Lands Long-Awaited FDA Approval

Supernus Pharmaceuticals’ Onapgo provides a continuous infusion of apomorphine to manage “off” periods experienced by Parkinson’s disease patients. Approval of Onapgo comes after the FDA twice turned back applications for the drug/device combination product. The post Supernus Wearable Device for Dosing Parkinson’s Drug Lands Long-Awaited FDA Approval appeared first on MedCity News.

Read More

Experian Health ranked #1 in Best in KLAS for 2025

Experian Health is very pleased to announce that we’ve ranked #1 in the 2025 Best in KLAS: Software & Services report, for our Contract Manager and Contract Analysis product, for the third consecutive year. Contract Manager, when paired with Contract Analysis, empowers healthcare providers by ensuring payers comply with contract terms, identifying and recovering underpayments, and arming them…

Read More

The Opportunities and Realities of Citizen-Initiated State Ballot Abortion Measures

Presidential candidate Trump claims credit for SCOTUS’ Dobbs decision and says that as a result, the “states are voting.” States are making decisions on abortion policy, but it’s mostly been state legislatures, not voters. Few states with abortion bans have a process for citizen-initiated constitutional amendments. In those states, lawmakers and anti-abortion activists have attempted…

Read More